Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Applied Nanoscience to Assist Emergency Filtration Products in Response to FDA Comments

Abstract:
Applied Nanoscience Inc. (ANI) (PINKSHEETS: APNN), a nanotechnology-based filtration development company, today announced that it has committed to fully assist its future merger partner Emergency Filtration Products, Inc. (EFP), the developer of the NanoMask™, in the response to comments issued by the U.S. Food and Drug Administration (FDA) in relation to the 510(k) pre-market notification filed by EFP in connection with the NanoMask.

Applied Nanoscience to Assist Emergency Filtration Products in Response to FDA Comments

CARLSBAD, CA and LAS VEGAS, NV | Posted on September 19th, 2008

"We have been working diligently to help EFP prepare the response to FDA comments regarding the NanoMask pre-market notification, especially as it relates to the antimicrobial silver nanoparticle formulation which powers the NanoMask," said Thomas K. Allen, President and CEO, ANI. "Applied Nanoscience's management and scientific team plan to rapidly provide EFP with the necessary data to satisfy the FDA comments."

####

About Applied Nanoscience Inc.
ANI is a marketer and developer of innovative, high performance nanotechnology-based filtration products (NanoFense™) to customers worldwide and is the owner of NEFT™ (Nanoparticle - Enhanced - Filtration - Technology), a broad platform with significant application potential.

EFP is a filtration technology company that has a unique and highly efficient hydrophobic micro-particle silver nanoparticle coated medical air filter mask, the NanoMask, which is designed to reduce bioburden on contact for in diverse high challenge medical filtration venues. EFP has recently submitted a 510(k) medical device notification with the FDA for its surgical NanoMask.

Safe Harbor Statement

This release may contain statements that are forward-looking. Such statements are made based upon current expectations that are subject to risk and uncertainty. EFP and ANI do not undertake to update forward-looking statements in this news release to reflect actual results of and changes in assumptions or changes in other factors affecting such forward-looking information. The actual future plans and results of the companies could differ significantly from such forward-looking statements.

For more information, please click here

Contacts:
Philippe Niemetz
800-477-7570 or 212-344-6464

Investor Relations
PAN Consultants Ltd.

Copyright © Marketwire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) September 25th, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

Govt.-Legislation/Regulation/Funding/Policy

UT engineers develop first method for controlling nanomotors: Breakthrough for nanotechnology as UT engineers develop first method for switching the mechanical motion of nanomotors September 21st, 2018

Researchers develop microbubble scrubber to destroy dangerous biofilms September 19th, 2018

Researchers managed to prevent the disappearing of quantum information September 14th, 2018

New photonic chip promises more robust quantum computers September 14th, 2018

Acquisitions/Mergers/Splits

Bruker Announces Acquisition of Nanoindenting Leader Hysitron: Acquisition strengthens Bruker’s leading position in nanoanalysis and nanomechanical materials characterization January 24th, 2017

GLOBALFOUNDRIES Completes Acquisition of IBM Microelectronics Business: Transaction adds differentiating technologies, world-class technologists, and intellectual property July 1st, 2015

Entest BioMedical, Inc. in Discussions to Acquire Nanotechnology Delivery System for Cancer Therapy June 3rd, 2015

Evident Thermoelectrics Acquires GMZ Energy: Investment Accelerates Launch Of Evident's Thermoelectric Modules For Waste Heat May 20th, 2015

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project